MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 3 analysts with an average price target of $20.81. This is a potential upside of $-7.78 (-27.21%) from yesterday's end of day stock price of $28.59.

Mersana Therapeutics's activity chart (see below) currently has 39 price targets and 39 ratings on display. The stock rating distribution of MRSN is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.69% with an average time for these price targets to be met of 368 days.

Highest price target for MRSN is $30.75, Lowest price target is $3, average price target is $21.25.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 13-Nov-2025. First documented stock forecast 15-Feb-2018.

Currently out of the existing stock ratings of MRSN, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$30.75

$3.32 (12.10%)

$36

1 months 2 days ago
(13-Nov-2025)

1/3 (33.33%)

$3.35 (12.23%)

25

Buy

$30

$2.57 (9.37%)

$5

4 months 1 days ago
(14-Aug-2025)

0/2 (0%)

$22.58 (304.31%)

Buy

$3

$-24.43 (-89.06%)

7 months 9 days ago
(06-May-2025)

1/2 (50%)

$-4.93 (-62.17%)

585

1 years 9 months 16 days ago
(29-Feb-2024)

1/3 (33.33%)

$10.19 (175.39%)

28

1 years 9 months 16 days ago
(29-Feb-2024)

0/2 (0%)

$10.19 (175.39%)

Show more analysts

Please expand the browser size to see the chart

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 368 days on average for the stock forecasts to be realized with a an average price target met ratio 55.69

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 2 price targets and 3 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Michael Ulz with highest potential upside - $25.74

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

David Nierengarten with lowest potential downside - -$24.43

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?